Medical imaging professionals are well known for their sharp eyesight and attention to detail, so many regular readers will no doubt have spotted the smart new logo in the bottom left corner of Diagnostic Imaging Europe's cover. We have tried to listen to the views of editorial advisors and online visitors and have redesigned our website. You should now find it cleaner and easier to navigate, and we hope you can identify the most important features more quickly.
Medical imaging professionals are well known for their sharp eyesight and attention to detail, so many regular readers will no doubt have spotted the smart new logo in the bottom left corner of Diagnostic Imaging Europe's cover. We have tried to listen to the views of editorial advisors and online visitors and have redesigned our website. You should now find it cleaner and easier to navigate, and we hope you can identify the most important features more quickly.
The daily news article remains a hugely popular part of the site, and it certainly makes it worth logging on each day. If a big industry story breaks, or if pioneering research findings are presented at an international conference or published in a peer-reviewed journal, then you can read about it free of charge on DiagnosticImaging.com.
Digital editions of our global magazines can also be viewed using NXTbook software. Alternatively, they can be downloaded as PDF files. If you miss an issue or need to check a previous article, you can use the comprehensive online archives. Electronic copies of DI Europe from December 2004 onwards and issues of Diagnostic Imaging (U.S.) from March 2005 are available.
Anybody searching for practical, objective, and up-to-date information about PACS can view DI's series of Enterprise Imaging & IT supplements. Original viewpoint columns about nephrogenic systemic fibrosis, radiology practice, MR safety, and other hot topics are other attractive features.
We hope you make full use of the new look website. If you have any comments or suggestions, please contact me at di-europe@btconnect.com.
It is very rare that the portrait of a person appears as the main image on DI Europe's front cover, so you may be surprised to see Dr. Harald Ostensen's photo in prime position on this month's cover. Given his immense contribution to training and education in developing countries, I am sure you will agree that his presence in this slot is justified.
The cover story about Ostensen's work is based on my interview with him in Berlin at the end of May. I met him off the night train from Zurich at the stunning Hauptbahnhof, which became Europe's largest two-level railway station when it opened in May 2006. When we started chatting over coffee and croissants, I produced the tricks of my trade: tape recorders, microphones, and the obligatory pen and notebook. The situation clearly amused him, and we joked that only the dark sunglasses and shabby raincoats were missing in this seemingly clandestine liaison in a city with a long history of intrigue and espionage.
Ostensen's affable manner and sense of humor partly explain why his colleagues think so highly of him. He is a determined individual with a strong network of loyal contacts, but he refuses to take himself too seriously. Such an approach has helped him cope with the ups and downs of the job.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.